Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Comparative Efficacy and Safety Of Dabigatran Etexilate and Rivaroxaban For The Treatment Of Deep Vein Thrombosis and Pulmonary Embolism

Andreas Clemens, MD, Shaun Abeysinghe, PhD, Ann-Katrin Gonschior, PhD, Volker Hösel, PhD, Sarah Lock, BSc, Sorrel E Wolowacz, PhD, Mathew Woods, MSc, Evelina Zimovetz, MSc

Blood (2013) 122 (21): 4807.

https://doi.org/10.1182/blood.V122.21.4807.4807

Published: 2013

Journal Articles

Real-World Study of Dabigatran Etexilate for Thromboprophylaxis in Over 5000 Hip or Knee Replacement Patients: Favourable Safety Profile in Subgroups with Different BMI, Renal Function and Age

Nadia Rosencher, MD, Simon Frostick, MD, Martin Feuring, MD, Eva Kleine, Martina Brueckmann, MD, Andreas Clemens, MD, Charles Marc Samama, MD

Blood (2012) 120 (21): 1160.

https://doi.org/10.1182/blood.V120.21.1160.1160

Published: 2012

Journal Articles

Epidemiological Data On the Incidence of Co-Morbidities and Co-Medications in Patients Undergoing Total Hip or Knee Replacement Surgery: Real-World Study and Phase III Clinical Trials.

Nadia Rosencher, MD, Simon Frostick, MD, Martin Feuring, MD, Eva Kleine, Martina Brueckmann, MD, Andreas Clemens, MD, Charles Marc Samama, MD

Blood (2012) 120 (21): 2269.

https://doi.org/10.1182/blood.V120.21.2269.2269

Published: 2012

Journal Articles

Acceleration of Dabigatran Elimination by Activated Charcoal Perfusion and Hemodialysis in a Pig Model.

Jessica Lange, MD, Christian Thiel, MD, Karolin Thiel, MD, Wilfried Klingert, Kathrin Klingert, Alfred Königsrainer, MD, Stephan Formella, MD, Andreas Clemens, MD, Joanne van Ryn, PhD, Martin Schenk, PhD

Blood (2012) 120 (21): 2272.

https://doi.org/10.1182/blood.V120.21.2272.2272

Published: 2012

Journal Articles

Assessment of Cross-Reactivity in Three Different Fecal Occult Blood Test Systems with Dabigatran and Dabigatran Etexilate: Identification of Useful Test Methods

Ashley M Goss, PhD, Joanne van Ryn, PhD, Johanna Schurer, Andreas Clemens, MD

Blood (2012) 120 (21): 4360.

https://doi.org/10.1182/blood.V120.21.4360.4360

Published: 2012

Journal Articles

Evaluation of the Acute Coronary Syndrome Safety Profile of Dabigatran Etexilate in Patients Undergoing Major Orthopaedic Surgery: Findings From Four Phase III Trials

Bengt I Eriksson, MD, John J Smith, MD, PhD, Joseph Caprini, MD, Stefan Hantel, PhD, Andreas Clemens, MD, Martin Feuring, MD, Gregory W Barsness, MD

Blood (2011) 118 (21): 2309.

https://doi.org/10.1182/blood.V118.21.2309.2309

Published: 2011

Journal Articles

Oral Dabigatran Etexilate Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty: A Pooled Analysis of Four Randomized Trials

Michael H Huo, MD, Andreas A Kurth, MD, Ola E Dahl, MD, Andreas Clemens, MD, Stefan Hantel, PhD, Martin Feuring, MD, Richard J Friedman, MD, Bengt I Eriksson, MD, PhD

Blood (2011) 118 (21): 2312.

https://doi.org/10.1182/blood.V118.21.2312.2312

Published: 2011

Journal Articles

The Successful Reversal of Dabigatran-Induced Bleeding by Coagulation Factor Concentrates in a Rat Tail Bleeding Model Do Not Correlate with Ex Vivo Markers of Anticoagulation

Joanne van Ryn, PhD, Johanna Schurer, Monika Kink-Eiband, Andreas Clemens, MD

Blood (2011) 118 (21): 2316.

https://doi.org/10.1182/blood.V118.21.2316.2316

Published: 2011

Journal Articles

Incidence of Vascular Outcomes in Patients with Atrial Fibrillation,

Arlene M Gallagher, Tarita Murray-Thomas, Andreas Clemens, MD, Ackermann Diana, Dorothee B Bartels, PhD, MSc

Blood (2011) 118 (21): 4223.

https://doi.org/10.1182/blood.V118.21.4223.4223

Published: 2011

Journal Articles

Adsorption of Dabigatran Etexilate in Water or Dabigatran in Pooled Human Plasma by Activated Charcoal in Vitro.

Joanne van Ryn, PhD, Peter Sieger, PhD, Monika Kink-Eiband, Dietmar Gansser, PhD, Andreas Clemens, MD

Blood (2009) 114 (22): 1065.

https://doi.org/10.1182/blood.V114.22.1065.1065

Published: 2009

NARROW

Comparative Efficacy and Safety Of Dabigatran Etexilate and Rivaroxaban For The Treatment Of Deep Vein Thrombosis and Pulmonary Embolism

Real-World Study of Dabigatran Etexilate for Thromboprophylaxis in Over 5000 Hip or Knee Replacement Patients: Favourable Safety Profile in Subgroups with Different BMI, Renal Function and Age

Epidemiological Data On the Incidence of Co-Morbidities and Co-Medications in Patients Undergoing Total Hip or Knee Replacement Surgery: Real-World Study and Phase III Clinical Trials.

Acceleration of Dabigatran Elimination by Activated Charcoal Perfusion and Hemodialysis in a Pig Model.

Assessment of Cross-Reactivity in Three Different Fecal Occult Blood Test Systems with Dabigatran and Dabigatran Etexilate: Identification of Useful Test Methods

Evaluation of the Acute Coronary Syndrome Safety Profile of Dabigatran Etexilate in Patients Undergoing Major Orthopaedic Surgery: Findings From Four Phase III Trials

Oral Dabigatran Etexilate Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Hip or Knee Arthroplasty: A Pooled Analysis of Four Randomized Trials

The Successful Reversal of Dabigatran-Induced Bleeding by Coagulation Factor Concentrates in a Rat Tail Bleeding Model Do Not Correlate with Ex Vivo Markers of Anticoagulation

Incidence of Vascular Outcomes in Patients with Atrial Fibrillation,

Adsorption of Dabigatran Etexilate in Water or Dabigatran in Pooled Human Plasma by Activated Charcoal in Vitro.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only